# ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

> **NCT07089420** · — · COMPLETED · sponsor: **American Laboratory Products Company** · enrollment: 121 (actual)

## Conditions studied

- IBD (Inflammatory Bowel Disease)
- IBS - Irritable Bowel Syndrome
- Crohn Disease (CD)
- UC - Ulcerative Colitis

## Interventions

- **DEVICE:** ALPCO Calprotectin CLIA

## Key facts

- **NCT ID:** NCT07089420
- **Lead sponsor:** American Laboratory Products Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-07
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089420, "ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07089420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*